• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Generic Pharmaceuticals Market – A Global Analysis

  • ID: 2039981
  • December 2011
  • Region: Global
  • 213 Pages
  • Frost & Sullivan

Time is Ripe for Generics Manufacturers as Key Blockbuster Drugs Set to go Off-patent

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers, worldwide. At the same time, the balance in terms of healthcare expenditure and sales revenue is poised to shift from developed to emerging markets such as India, China, Brazil, Russia, Turkey and South Korea, as huge potential still remains untapped in these countries.

“The patent expiry of several major blockbuster drugs worth $150 billion between 2010 and 2017 will fuel the growth of the global generic pharmaceuticals market,” notes the analyst of this research. “The trend is shifting towards less competitive, yet commercially attractive, segments such as difficult-to-produce generics, specialty generics and biosimilars.” Leading global generic pharmaceuticals manufacturers have been proactive in forging strategic alliances with branded pharmaceutical companies for marketing rights and exclusivity in producing generic READ MORE >

Note: Product cover images may vary from those shown

1. Executive Summary

2. Introduction

3. Market Overview

4. External Challenges, Market Drivers and Restraints - Total Market

5. Market Trends and Revenue Forecasts - Total Market

6. Key Therapeutic Areas Analysis

7. Market Share and Competitive Landscape Analysis - Total Market

8. Industry Consolidation - Mergers & Acquisitions

9. United States Generic Pharmaceuticals Market

10. European Generic Pharmaceuticals Market

11. Key Five Generic Pharmaceuticals Market in Europe

12. Indian Generic Pharmaceuticals Market

13. Chinese Generic Pharmaceuticals Market

14. The Last Word

15. Summary of Major Findings - Total Market

16. Appendix

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S